ArticleJournal of cellular and molecular medicine2024
Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging.
Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
J. Cao, H. Wang, G. Liu, R. Tang, Y. Ding, P. Xu, H. Wang, J. Miao, X. Gu, and S. Han, 'LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging', Journal of Cellular and Molecular Medicine 25, no. 2 (2021): 1178-1189, https://doi.org/10.1111/jcmm.16185. The above article, published online on 20 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figure 2C, D, E and 5C) between this and other articles that were either previously published or published later in the same year. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed of the decision to retract but did not respond to the retraction decision or the wording.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.